Allarity Therapeutics Stock (NASDAQ: ALLR) stock price, news, charts, stock research, profile.
Open | $2.23 |
Close | $2.21 |
Volume / Avg. | 332.76K / 436.08K |
Day Range | $2.04 - $2.29 |
52 Wk Range | 1.78 - 666.00 |
Market Cap | $3.04M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 40.86% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Allarity Therapeutics (NASDAQ:ALLR) through any online brokerage.
Other companies in Allarity Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Trevena (NASDAQ:TRVN).
There is no analysis for Allarity Therapeutics to provide a consensus price target.
The stock price for Allarity Therapeutics (NASDAQ: ALLR) is $2.15 last updated September 20, 2024 at 7:10 PM EDT.
There are no upcoming dividends for Allarity Therapeutics.
Allarity Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Allarity Therapeutics.
Allarity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.